Cabozantinib in Patients with Advanced Merkel Cell Carcinoma

BACKGROUND. This study sought to determine the efficacy and safety profile of cabozantinib in patients with advanced Merkel cell carcinoma (MCC). EXPERIMENTAL DESIGN. This prospective, phase II, single‐institution trial enrolled patients with platinum‐failure, recurrent/metastatic MCC to receive cab...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Rabinowits, Guilherme, Lezcano, Cecilia, Catalano, Paul J., McHugh, Patricia, Becker, Hailey, Reilly, Megan M., Huang, Julian, Tyagi, Ayushi, Thakuria, Manisha, Bresler, Scott C., Sholl, Lynette M., Shapiro, Geoffrey I., Haddad, Robert, DeCaprio, James A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2018
Soggetti:
Melanoma and Cutaneous Malignancies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058327/
https://ncbi.nlm.nih.gov/pubmed/29445030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0552
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi